Sholzberg M, Gwathmey K, Broome CM, Goebeler M, Murai H, Bata-Csörgo Z, Newland A, Ulrichts P, Kerstens R, Guptill JT, Agha S, Jiang M, Howard Jr JF. Overview of the Safety Profile From Efgartigimod Clinical Trials in Participants With Diverse IgG-Mediated Autoimmune Diseases. J of Skin [Internet]. 2024 Jan. 16 [cited 2024 Jul. 3];8(1):s344. Available from: https://jofskin.org/33014/index.php/skin/article/view/2350